Tumor-targeting multifunctional nanoparticles for sirna delivery: Recent advances in cancer therapy

Sook Hee Ku, Kwang Meyung Kim, Kuiwon Choi, Sun Hwa Kim, Ick Chan Kwon

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

RNA interference (RNAi) is a naturally occurring regulatory process that controls posttranscriptional gene expression. Small interfering RNA (siRNA), a common form of RNAi-based therapeutics, offers new opportunities for cancer therapy via silencing specific genes, which are associated to cancer progress. However, clinical applications of RNAi-based therapy are still limited due to the easy degradation of siRNA during body circulation and the difficulty in the delivery of siRNA to desired tissues and cells. Thus, there have been many efforts to develop efficient siRNA delivery systems, which protect siRNA from serum nucleases and deliver siRNA to the intracellular region of target cells. Here, the recent advances in siRNA nanocarriers, which possess tumor-targeting ability are reviewed; various nanoparticle systems and their antitumor effects are summarized. The development of multifunctional nanocarriers for theranostics or combinatorial therapy is also discussed.

Original languageEnglish
Pages (from-to)1182-1193
Number of pages12
JournalAdvanced healthcare materials
Volume3
Issue number8
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

RNA
Nanoparticles
Small Interfering RNA
Tumors
RNA Interference
Neoplasms
Therapeutics
Gene Silencing
Ribonucleases
Gene expression
Process control
Genes
Tissue
Gene Expression
Degradation
Serum

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Pharmaceutical Science

Cite this

Tumor-targeting multifunctional nanoparticles for sirna delivery : Recent advances in cancer therapy. / Ku, Sook Hee; Kim, Kwang Meyung; Choi, Kuiwon; Kim, Sun Hwa; Kwon, Ick Chan.

In: Advanced healthcare materials, Vol. 3, No. 8, 01.01.2014, p. 1182-1193.

Research output: Contribution to journalArticle

Ku, Sook Hee ; Kim, Kwang Meyung ; Choi, Kuiwon ; Kim, Sun Hwa ; Kwon, Ick Chan. / Tumor-targeting multifunctional nanoparticles for sirna delivery : Recent advances in cancer therapy. In: Advanced healthcare materials. 2014 ; Vol. 3, No. 8. pp. 1182-1193.
@article{ec0902f5501b4648a2f122a587cc9ba5,
title = "Tumor-targeting multifunctional nanoparticles for sirna delivery: Recent advances in cancer therapy",
abstract = "RNA interference (RNAi) is a naturally occurring regulatory process that controls posttranscriptional gene expression. Small interfering RNA (siRNA), a common form of RNAi-based therapeutics, offers new opportunities for cancer therapy via silencing specific genes, which are associated to cancer progress. However, clinical applications of RNAi-based therapy are still limited due to the easy degradation of siRNA during body circulation and the difficulty in the delivery of siRNA to desired tissues and cells. Thus, there have been many efforts to develop efficient siRNA delivery systems, which protect siRNA from serum nucleases and deliver siRNA to the intracellular region of target cells. Here, the recent advances in siRNA nanocarriers, which possess tumor-targeting ability are reviewed; various nanoparticle systems and their antitumor effects are summarized. The development of multifunctional nanocarriers for theranostics or combinatorial therapy is also discussed.",
keywords = "Cancer therapy, Multifunctional nanoparticles, SiRNA delivery, Tumor targeting",
author = "Ku, {Sook Hee} and Kim, {Kwang Meyung} and Kuiwon Choi and Kim, {Sun Hwa} and Kwon, {Ick Chan}",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/adhm.201300607",
language = "English",
volume = "3",
pages = "1182--1193",
journal = "Advanced healthcare materials",
issn = "2192-2640",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Tumor-targeting multifunctional nanoparticles for sirna delivery

T2 - Recent advances in cancer therapy

AU - Ku, Sook Hee

AU - Kim, Kwang Meyung

AU - Choi, Kuiwon

AU - Kim, Sun Hwa

AU - Kwon, Ick Chan

PY - 2014/1/1

Y1 - 2014/1/1

N2 - RNA interference (RNAi) is a naturally occurring regulatory process that controls posttranscriptional gene expression. Small interfering RNA (siRNA), a common form of RNAi-based therapeutics, offers new opportunities for cancer therapy via silencing specific genes, which are associated to cancer progress. However, clinical applications of RNAi-based therapy are still limited due to the easy degradation of siRNA during body circulation and the difficulty in the delivery of siRNA to desired tissues and cells. Thus, there have been many efforts to develop efficient siRNA delivery systems, which protect siRNA from serum nucleases and deliver siRNA to the intracellular region of target cells. Here, the recent advances in siRNA nanocarriers, which possess tumor-targeting ability are reviewed; various nanoparticle systems and their antitumor effects are summarized. The development of multifunctional nanocarriers for theranostics or combinatorial therapy is also discussed.

AB - RNA interference (RNAi) is a naturally occurring regulatory process that controls posttranscriptional gene expression. Small interfering RNA (siRNA), a common form of RNAi-based therapeutics, offers new opportunities for cancer therapy via silencing specific genes, which are associated to cancer progress. However, clinical applications of RNAi-based therapy are still limited due to the easy degradation of siRNA during body circulation and the difficulty in the delivery of siRNA to desired tissues and cells. Thus, there have been many efforts to develop efficient siRNA delivery systems, which protect siRNA from serum nucleases and deliver siRNA to the intracellular region of target cells. Here, the recent advances in siRNA nanocarriers, which possess tumor-targeting ability are reviewed; various nanoparticle systems and their antitumor effects are summarized. The development of multifunctional nanocarriers for theranostics or combinatorial therapy is also discussed.

KW - Cancer therapy

KW - Multifunctional nanoparticles

KW - SiRNA delivery

KW - Tumor targeting

UR - http://www.scopus.com/inward/record.url?scp=84906077659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906077659&partnerID=8YFLogxK

U2 - 10.1002/adhm.201300607

DO - 10.1002/adhm.201300607

M3 - Article

C2 - 24577795

AN - SCOPUS:84906077659

VL - 3

SP - 1182

EP - 1193

JO - Advanced healthcare materials

JF - Advanced healthcare materials

SN - 2192-2640

IS - 8

ER -